Using absolute prostate-specific antigen (PSA) thresholds to make decisions about diagnostic testing and biopsies remains controversial (Journal Watch Top Story Dec 31 2004), but PSA velocity (the ...

A new article focuses on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection. The November issue of ...

We need better ways to determine which prostate-specific antigen (PSA)-detected localized prostate cancers are most likely to progress. The rate at which the PSA level rises (i.e., PSA velocity) prior ...

Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic ...

We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...

The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study. The most significant single ...

Serum PSA values >4.0 ng/ml are routinely used to select patients for prostate biopsy, although this approach misses some early-stage cancers. Some researchers advocate dropping the PSA threshold to 2 ...

PSA blood test Compared with absolute PSA, PSA velocity associated more with increased likelihood of progression among men on active surveillance for prostate cancer. PSA velocity (PSAV) is associated ...

Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be ...

Prostate cancer is much more likely to kill if a man’s PSA level rises rapidly before the cancer is even diagnosed, according to a study that suggests a new and far more meaningful way of looking at ...

We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...

Arnhem, November 2009 – The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity ...